Makes and sells nutrition ingredients, performance gases and chemicals, and plant nutrients to food and beverage makers, animal producers, and medical-device sterilizers.
10-K for FY2025, filed Feb 20, 2026The Human Nutrition and Health ("HNH") segment provides human grade choline nutrients and mineral amino acid chelated products for…View ↗
The Company’s Animal Nutrition and Health ("ANH") segment provides nutritional products derived from its microencapsulation and chelation…View ↗
The Company's Specialty Products ("SP") segment re-packages and distributes a number of performance gases and chemicals for various uses by…View ↗
The Company’s micronutrient agricultural nutrition business sells chelated minerals primarily to producers of high value crops. The Company…View ↗
Customers place orders for products, and Balchem earns the sale when it fulfills the order; it also earns sales-based royalties over time when customers use its intellectual property.
10-K for FY2025, filed Feb 20, 2026
10-K for FY2025, filed Feb 20, 2026
FY2025 revenue by product or service ↗$1B
10-K for FY2025, filed Feb 20, 2026
$1B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product Sales Revenue
Sold outright
10-K for FY2025, filed Feb 20, 2026 |
100%
FY2022: 100%
|
Product Sales Revenue, FY2025
$1B Sources
|
Sold outright |
|
Royalty Revenue
Licensed
|
0.2%
FY2022: 0.3%
|
Royalty Revenue, FY2025
$1.9M Sources
|
Licensed |
Balchem sells through its own sales force, independent distributors and sales agents; contract sterilizers and medical-device manufacturers are principal buyers of ethylene oxide.
10-K for FY2025, filed Feb 20, 2026
Yes. It kept 15 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.
10-Q for Q3 FY2026, filed Oct 23, 2026
$46.7MView ↗
10-Q for Q3 FY2026, filed Oct 23, 2026
Open tableView ↗
Growing. Revenue grew 30% in 4 years, from $799M in FY2021 to $1B in FY2025, about 7% a year.
Loading...